BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 14993453)

  • 1. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
    Hnasko R; Lisanti MP
    Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of caveolae and caveolins in health and disease.
    Cohen AW; Hnasko R; Schubert W; Lisanti MP
    Physiol Rev; 2004 Oct; 84(4):1341-79. PubMed ID: 15383654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.
    Drab M; Verkade P; Elger M; Kasper M; Lohn M; Lauterbach B; Menne J; Lindschau C; Mende F; Luft FC; Schedl A; Haller H; Kurzchalia TV
    Science; 2001 Sep; 293(5539):2449-52. PubMed ID: 11498544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolin-1 null (-/-) mice show dramatic reductions in life span.
    Park DS; Cohen AW; Frank PG; Razani B; Lee H; Williams TM; Chandra M; Shirani J; De Souza AP; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
    Biochemistry; 2003 Dec; 42(51):15124-31. PubMed ID: 14690422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic ablation of caveolin-1 confers protection against atherosclerosis.
    Frank PG; Lee H; Park DS; Tandon NN; Scherer PE; Lisanti MP
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):98-105. PubMed ID: 14563650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression.
    Jasmin JF; Mercier I; Hnasko R; Cheung MW; Tanowitz HB; Dupuis J; Lisanti MP
    Cardiovasc Res; 2004 Sep; 63(4):747-55. PubMed ID: 15306231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolin-1 and -2 in airway epithelium: expression and in situ association as detected by FRET-CLSM.
    Krasteva G; Pfeil U; Drab M; Kummer W; König P
    Respir Res; 2006 Aug; 7(1):108. PubMed ID: 16904002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary analysis and molecular dissection of caveola biogenesis.
    Kirkham M; Nixon SJ; Howes MT; Abi-Rached L; Wakeham DE; Hanzal-Bayer M; Ferguson C; Hill MM; Fernandez-Rojo M; Brown DA; Hancock JF; Brodsky FM; Parton RG
    J Cell Sci; 2008 Jun; 121(Pt 12):2075-86. PubMed ID: 18505796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin, caveolae, and endothelial cell function.
    Frank PG; Woodman SE; Park DS; Lisanti MP
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1161-8. PubMed ID: 12689915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Caveolin genes: from cell biology to medicine.
    Williams TM; Lisanti MP
    Ann Med; 2004; 36(8):584-95. PubMed ID: 15768830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease.
    Xu Y; Buikema H; van Gilst WH; Henning RH
    Eur J Pharmacol; 2008 May; 585(2-3):256-60. PubMed ID: 18423600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease.
    Quest AF; Leyton L; Párraga M
    Biochem Cell Biol; 2004 Feb; 82(1):129-44. PubMed ID: 15052333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Caveolae membrane domains, specialized transmembrane exchange zones implicated in cell signalling].
    Roch-Arveiller M; Couderc R
    Ann Biol Clin (Paris); 2000; 58(2):141-6. PubMed ID: 10760700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.
    Park DS; Woodman SE; Schubert W; Cohen AW; Frank PG; Chandra M; Shirani J; Razani B; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
    Am J Pathol; 2002 Jun; 160(6):2207-17. PubMed ID: 12057923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cav-p60 expression in rat muscle tissues. Distribution of caveolar proteins.
    Voldstedlund M; Vinten J; Tranum-Jensen J
    Cell Tissue Res; 2001 Nov; 306(2):265-76. PubMed ID: 11702238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Getting rid of caveolins: phenotypes of caveolin-deficient animals.
    Le Lay S; Kurzchalia TV
    Biochim Biophys Acta; 2005 Dec; 1746(3):322-33. PubMed ID: 16019085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell biology. Life without caveolae.
    Parton RG
    Science; 2001 Sep; 293(5539):2404-5. PubMed ID: 11577223
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell biology of caveolae and its implication for clinical medicine.
    Fujimoto T
    Nagoya J Med Sci; 2000 May; 63(1-2):9-18. PubMed ID: 10911716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.